Wolverine Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,244
| Closed | -$119K | – | 1708 |
|
|
2020
Q4 | $119K | Buy |
+2,244
| New | +$119K | ﹤0.01% | 914 |
|
|
2020
Q3 | – | Sell |
-40
| Closed | -$1K | – | 1224 |
|
|
2020
Q2 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 1168 |
|
|
2016
Q1 | – | Sell |
-850
| Closed | -$30K | – | 712 |
|
|
2015
Q4 | $30K | Hold |
850
| – | – | ﹤0.01% | 847 |
|
|
2015
Q3 | $28K | Buy |
+850
| New | +$28K | ﹤0.01% | 895 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1014 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 965 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1056 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 1122 |
|
|
2014
Q1 | – | Sell |
-18,600
| Closed | -$464K | – | 1054 |
|
|
2013
Q4 | $464K | Buy |
18,600
+10,000
| +116% | +$249K | 0.01% | 638 |
|
|
2013
Q3 | $236K | Buy |
8,600
+3,600
| +72% | +$98.8K | 0.01% | 790 |
|
|
2013
Q2 | $90K | Buy |
+5,000
| New | +$90K | ﹤0.01% | 898 |
|